Should Natera prioritize expanding its Panorama prenatal test coverage to more genetic conditions or focus on reducing turnaround time for existing tests?

Introduction

The trade-off we're examining today is whether Natera should prioritize expanding its Panorama prenatal test coverage to more genetic conditions or focus on reducing turnaround time for existing tests. This decision involves balancing the breadth of our diagnostic capabilities against the speed of delivering results to expectant parents and healthcare providers. I'll analyze this trade-off through multiple lenses, considering business impact, user needs, technical feasibility, and long-term strategic implications.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking about Natera's current market position. Could you share our current market share in the prenatal testing space and how it compares to our main competitors?

Why it matters: Helps assess whether expansion or speed is more critical for competitive advantage Expected answer: Natera has a strong but not dominant position, with 2-3 major competitors Impact on approach: If market leader, might favor expansion; if trailing, speed could be key

• Business Context: Based on our revenue model, I assume most of our income comes from insurance reimbursements. Is this correct, and how does our pricing compare for different test types?

Why it matters: Influences whether expanding test types or reducing turnaround time would have a bigger financial impact Expected answer: Primarily insurance-based, with some direct-to-consumer options Impact on approach: If reimbursement rates vary significantly by test type, might favor expansion

• User Impact: I'm curious about our user feedback. What's the most common complaint or request from patients and healthcare providers regarding our Panorama test?

Why it matters: Directly informs which option would address user needs more effectively Expected answer: Mix of requests for more comprehensive testing and faster results Impact on approach: Would prioritize the option that aligns more closely with user demands

• Technical: Regarding our current testing process, what's the main bottleneck in our turnaround time? Is it sample processing, analysis, or reporting?

Why it matters: Helps assess the feasibility and potential impact of reducing turnaround time Expected answer: Analysis is the primary bottleneck due to complex data processing Impact on approach: If easily addressable, might favor speed improvement

• Resource: Can you give me an idea of our current R&D capacity? Are we better positioned to develop new tests or optimize existing processes?

Why it matters: Determines which option is more achievable with current resources Expected answer: Balanced capabilities, with slight edge in process optimization Impact on approach: Would lean towards the option that aligns with our stronger capabilities